Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
Aclarion has launched a Market Access Program in partnership with PRIA Healthcare to advance reimbursement and commercial adoption of its AI-powered Nociscan platform for chronic low back pain. The collaboration leverages PRIA’s expertise in payer engagement, prior authorization, and appeals management to streamline the reimbursement process for U.S. physicians and health systems. Nociscan has already secured payer approval from three of the top four private insurance companies in the UK, providing a validated foundation for Aclarion’s U.S.
Key figures
- Uk payer approvals
- 3 of top 4 private insurance companies
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.